Skip to main content

Table 3 Baseline characteristics of patients in study cohort

From: LDL-cholesterol change and goal attainment following statin intensity titration among Asians in primary care: a retrospective cohort study

Characteristics

No statin (n = 1156)

Non-titrators (n = 4916)

Titrators (n = 1565)

Full cohort (n = 11,499)

Total Patients, n (%)

1155 (100)

4916 (100)

1565 (100)

11,499 (100)

Age (year), mean (SD)

65.3 (11.0)

69.0 (10.3)

64.8 (10.0)

67.8 (11.3)

Sex, males, n (%)

461 (39.9)

2008 (40.8)

712 (45.5)

4967 (43.2)

Race, n (%)

 Chinese

1042 (90.2)

4185 (85.1)

1279 (81.7)

9606 (83.5)

 Malay

22 (1.9)

282 (5.7)

109 (7.0)

726 (6.3)

 Indian

55 (4.8)

236 (4.8)

105 (6.7)

655 (5.7)

 Others

36 (3.1)

213 (4.3)

72 (4.6)

512 (4.5)

Diagnosis, n (%)

 Dyslipidaemia

1155 (100.0)

4916 (100.0)

1565 (100.0)

11,499 (100.0)

 Diabetes

159 (13.8)

1915 (39.0)

594 (38.0)

4153 (36.1)

 Hypertension

793 (68.7)

4166 (84.7)

1120 (71.6)

9101 (79.1)

Years with Dyslipidaemia at base visit, n (%)

 0

196 (17.0)

226 (4.6)

177 (11.3)

1074 (9.3)

 1

76 (6.6)

298 (6.1)

125 (8.0)

797 (6.9)

 2

81 (7.0)

600 (12.2)

184 (11.8)

1350 (11.7)

 3

103 (8.9)

316 (6.4)

121 (7.7)

825 (7.2)

 4

183 (15.8)

417 (8.5)

159 (10.2)

1133 (9.9)

 > =5

516 (44.7)

3059 (62.2)

799 (51.0)

6320 (55.0)

Statin intensity at base visit, n (%)

 No

1155 (100.0)

0.0 (0.0)

333 (21.3)

2327 (20.2)

 Low

0.0 (0.0)

3998 (81.3)

850 (54.3)

7076 (61.5)

 Intermediate

0.0 (0.0)

812 (16.5)

349 (22.3)

1867 (16.2)

 High

0.0 (0.0)

106 (2.2)

33 (2.1)

229 (2.0)

Patients in each risk group, n (%)

 Low

515 (44.6)

1111 (22.6)

453 (28.9)

2970 (25.8)

 Intermediate

196 (17.0)

504 (10.3)

150 (9.6)

1162 (10.1)

 High

331 (28.7)

1827 (37.2)

484 (30.9)

3942 (34.3)

 Very high

113 (9.8)

1474 (30.0)

478 (30.5)

3425 (29.8)

Number of LDL tests per year, mean (SD)

0.8 (0.3)

0.8 (0.2)

1.0 (0.3)

0.7 (0.3)

Number of statinprescriptions per year, mean (SD)

0.0 (0.0)

2.6 (0.9)

2.4 (1.2)

2.3 (1.2)

  1. Abbreviations: LDL Low-density lipoprotein, SD Standard deviation